Free Trial

Genus (LON:GNS) Stock Passes Above 200-Day Moving Average - Here's Why

Genus logo with Medical background

Key Points

  • The share price of Genus plc (LON:GNS) recently crossed above its 200-day moving average and is currently trading at GBX 2,615 ($35.47).
  • Analysts have a consensus rating of "Buy" for Genus, with target prices ranging from GBX 2,550 to GBX 2,900.
  • Genus reported earnings of GBX 81.80 per share in its latest quarterly results and has a market capitalization of £1.72 billion.
  • MarketBeat previews top five stocks to own in November.

Genus plc (LON:GNS - Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 2,112.85 ($28.64) and traded as high as GBX 2,755 ($37.34). Genus shares last traded at GBX 2,615 ($35.44), with a volume of 70,297 shares changing hands.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Shore Capital reaffirmed a "buy" rating and set a GBX 2,900 price target on shares of Genus in a research report on Thursday, September 4th. Deutsche Bank Aktiengesellschaft increased their price target on Genus from GBX 2,550 to GBX 2,900 and gave the company a "buy" rating in a research report on Monday. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of GBX 2,900.

Read Our Latest Analysis on Genus

Genus Stock Down 1.8%

The company has a quick ratio of 1.08, a current ratio of 1.80 and a debt-to-equity ratio of 53.12. The stock has a 50-day simple moving average of GBX 2,538.66 and a 200-day simple moving average of GBX 2,132.15. The firm has a market capitalization of £1.63 billion, a PE ratio of -39,919.35, a P/E/G ratio of 2.87 and a beta of 0.37.

Genus (LON:GNS - Get Free Report) last released its earnings results on Thursday, September 4th. The company reported GBX 81.80 earnings per share (EPS) for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Analysts forecast that Genus plc will post 70.9644323 EPS for the current year.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Stories

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.